Novartis begins hunt for piece of Roche's growing MS empire

Novartis on Friday announced positive study results for its prospective multiple sclerosis drug ofatumumab that the Swiss drugmaker hopes will pose a stiff challenge to Roche's medicine Ocrevus in a highly competitive market.

from Reuters: Health News https://ift.tt/2PoVRZA
https://ift.tt/xePdMM